原著論文

• Sasabayashi D, Tsugawa S, Nakajima S, Takahashi T, Takayanagi Y, Koike S, Katagiri N, Katsura M, Furuichi A, Mizukami Y, Nishiyama S, Kobayashi H, Yuasa Y, Tsujino N, Sakuma A, Ohmuro N, Sato Y, Tomimoto K, Okada N, Tada M, Suga M, Maikusa N, Plitman E, Wannan C, Zalesky A, Chakravarty M, Noguchi K, Yamasue H, Matsumoto K, Nemoto T, Tomita H, Mizuno M, Kasai K, Suzuki M. Increased structural covariance of cortical measures in individuals with an at-risk mental state. Progress in Neuropsychopharmacology & Biological Psychiatry. 2025 Jan 10;136:111197. doi: 10.1016/j.pnpbp.2024.111197.
• Wakuda T, Benner S, Uemura Y, Nishimura T, Kojima M, Kuroda M, Matsumoto K, Kanai C, Inada N, Harada T, Kameno Y, Munesue T, Inoue J, Umemura K, Yamauchi A, Ogawa N, Kushima I, Suyama S, Saito T, Hamada J, Kano Y, Honda N, Kikuchi S, Seto M, Tomita H, Miyoshi N, Matsumoto M, Kawaguchi Y, Kanai K, Ikeda M, Nakamura I, Isomura S, Hirano Y, Onitsuka T, Ozaki N, Kosaka H, Okada T, Kuwabara H, Yamasue H*. Oxytocin-induced increases in cytokines and clinical effect on the core social features of autism: Analyses of RCT datasets. Brain Behavior and Immunity. 2024 May;118:398-407.
• Koshiyama D, Nishimura R, Usui K, Fujioka M, Tada M, Kirihara K, Araki T, Kawakami S, Okada N, Koike S, Yamasue H, Abe O, Kasai K. Cortical white matter microstructural alterations underlying impaired gamma-band auditory steady-state response in schizophrenia. Schizophrenia. 2024 Mar 12;10(1):32.
• Zhu Y, Maikusa N, Radua J, Sämann P, Fusar-Poli P, Agartzc I, Andreassen O, Bachman P, Choi S, Corcoran C, Ebdrup B, Fortea A, Garani R, Glenthøj B, Glenthøj L, Haas S, Hamilton H, Hayes R, He Y, Heekeren K, Kasai K, Katagiri N, Kim M, Kristensen T, Lawrie S, Lebedeva I, Lee J, Loewy R, Mathalon D, McGuire P, Mizrahi R, Mizuno M, Møller P, Nemoto T, Nordholm D, Omelchenko M, Raghava J, Røssberg J, Rössler W, Salisbury D, Sasabayashi D, Smigielski L, Sugranyes G, Takahashi T, Tamnes C, Tang J, Theodoridou A, Tomyshev A, Uhlhaas P, Værnes T, Amelsvoort T, Waltz J, Westlye L, Thompson P, Hernaus D, Jalbrzikowski M, Koike S*, and the ENIGMA Clinical High Risk for Psychosis Working Group. Using Brain Structural Neuroimaging Measures to Predict Psychosis Onset for Individualsat Clinical High-Risk. Molecular Psychiatry. 2024 Feb 9. doi: 10.1038/s41380-024-02426-7.
• Ochi K, Kojima K, Ono N, Kuroda M, Owada K, Sagayama S, Yamasue H. Objective Assessment of Autism Spectrum Disorder Based on Performance in Structured Interpersonal Acting-Out Tasks with Prosodic Stability and Variability. Autism Research. 2024 Feb;17(2):395-409.
• Lo T, Kushima I, Kimura H, Aleksic B, Okada T, Kato H, Inada T, Nawa Y, Torii Y, Yamamoto M, Kimura R, Funabiki Y, Kosaka H, Numata S, Kasai K, Sasaki T, Yokoyama S, Munesue T, Hashimoto R, Yasuda Y, Fujimoto M, Usami M, Itokawa M, Arai M, Ohi K, Someya T, Watanabe Y, Egawa J, Takahashi T, Suzuki M, Yamasue H, Iwata N, Ikeda M, Ozaki N. Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control study. Neuropsychopharmacology Reports. 2024 Mar;44(1):42-50. doi: 10.1002/npr2.12370.

2023

• ENIGMA Clinical High Risk for Psychosis Working Group; Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, Glenthøj LB, Haut KM, Hayes RA, Heekeren K, Hooker CI, Hwang WJ, Jahanshad N, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Koike S, Kristensen TD, Kwon JS, Lawrie SM, Lebedeva I, Lee J, Lemmers-Jansen ILJ, Lin A, Ma X, Mathalon DH, McGuire P, Michel C, Mizrahi R, Mizuno M, Møller P, Mora-Durán R, Nelson B, Nemoto T, Nordentoft M, Nordholm D, Omelchenko MA, Pantelis C, Pariente JC, Raghava JM, Reyes-Madrigal F, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Smigielski L, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Theodoridou A, Thomopoulos SI, Thompson PM, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TAMJ, van Erp TGM, Waltz JA, Wenneberg C, Westlye LT, Wood SJ, Zhou JH, Hernaus D, Jalbrzikowski M, Kahn RS, Corcoran CM, Frangou S. Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis. JAMA Psychiatry. 2024 Jan 1;81(1):77-88. doi: 10.1001/jamapsychiatry.2023.3850.
• Matsunaga M, Ohtsubo Y, Masuda T, Noguchi Y, Yamasue H, Ishii K. Exploratory research on genetic polymorphisms associated with positive empathy and trait forgivingness among the Japanese. Neuroendocrinology Letters. 2023 Dec 12;44(8):506-516.
• Kameno Y, Nishimura T, Naito Y, Asai D, Inoue J, Mochizuki Y, Isobe T, Hanada A, Enomoto N, Yamasue H. Time-course changes in mental distress and their predictors in response to the coronavirus disease 2019 (COVID-19) pandemic: A longitudinal multi-site study of hospital staff. PLOS ONE. 2023 Oct 5.
• Matsumoto J, Fukunaga M, Miura K, Nemoto K, Okada N, Hashimoto N, Morita K, Koshiyama K, a Ohi K, Takahashi T, Koeda M, Yamamori H, Fujimoto M, Yasuda Y, Ito S, Yamazaki R, Hasegawa N, Narita H, Yokoyama S, Mishima R, Miyata J, Kobayashi Y, Sasabayashi D, Harada K, Yamamoto M, Hirano Y, Itahashi T, Nakataki M, Hashimoto R, Tha K, Koike S, Matsubara T, Okada G, Yoshimura R, Abe O, GM van Erp T, Turner J, Jahanshad N, Thompson P, Onitsuka T, Watanabe Y, Matsuo K, Yamasue H, Okamoto Y, Suzuki M, Ozaki N, Kasai K, Hashimoto R. Cerebral cortical structural alteration patterns across four major psychiatric disorders in 5,549 individuals. Molecular Psychiatry. 2023 Nov;28(11):4915-4923. doi: 10.1038/s41380-023-02224-7.
• Sano F, Kikushima K, Benner S, Xu L, Kahyo T, Yamasue H, Setou M. Associations between prefrontal PI (16:0/20:4) lipid, TNC mRNA, and APOA1 protein in schizophrenia: A trans-omics analysis in post-mortem brain. Front Psychiatry. 2023 Apr 18;14:1145437. doi: 10.3389/fpsyt.2023.1145437.
• Okada N, Fukunaga M, Miura K, Nemoto K, Matsumoto J, Hashimoto N, Kiyota M, Morita K, Koshiyama D, Ohi K, Takahashi T, Koeda M, Yamamori H, Fujimoto M, Yasuda Y, Hasegawa N, Narita H, Yokoyama S, Mishima R, Kawashima T, Kobayashi Y, Sasabayashi D, Harada K, Yamamoto M, Hirano Y, Itahashi T, Nakataki M, Hashimoto R, Tha K, Koike S, Matsubara T, Okada G, Erp T, Jahanshad N, Yoshimura R, Abe O, Onitsuka T, Watanabe Y, Matsuo K, Yamasue H, Okamoto Y, Suzuki M, Turner J, Thompson P, Ozaki N, Kasai K, Hashimoto R. Subcortical volumetric alterations in four major psychiatric disorders: A mega-analysis study of 5604 subjects and a volumetric data-driven approach for classification. Molecular Psychiatry. 2023 Aug 4. doi: 10.1038/s41380-023-02141-9.
• Zhai Q, Islam A, Chen B, Zhang H, Chi D, Mamun A,Takahashi Y, Sato N, Yamasue H, Nakajima Y, Nagashima Y, Sano F, Sato T, Kahyo T, Setou M. Endocannabinoid 2-Arachidonoylglycerol Levels in the Anterior Cingulate Cortex, Caudate Putamen, Nucleus Accumbens, and Piriform Cortex Were Upregulated by Chronic Restraint Stress. Cells. 2023;12(3): 393.
• Merritt M, McCutcheon R, Aleman A, Block W, Bloemen O, Borgan F, Bustillo J, Capizzano A, Coughlin J, Fuente-Sandoval C, Demjaha A, Dempster K, Do K, Fei Du, Falkai P, Galińska-Skok B, Gallinat J, Gasparovic C, Ginestet C, Goto N, Graff-Guerrero A, Ho B, Oliver Howes O, Jauhar S, Jeon P, Kato T, Kaufmann C, Keshavan M, Kim S, Kunugi H, Lauriello J, Liemburg E, Meghan M, Modinos G, Mouchlianitis E, Nakamura J, Nenadic I, Ongur D, Ota M, Palaniyappan L, Pantelis C, Plitman E, Posporelis S, Reichenbach J, Renshaw P, Russell B, Sawa A, Schaefer M, Shungu D, Smesny S, Stanley J, Stone J, Szulc A, Taylor R, Thakkar K, Théberge J, Tibbo P, Amelsvoort van T, Walecki J, Williamson P, Wood S, Xin L , Yamasue H, León-Ortiz P, Reyes-Madrigal F, Ashley S, Patel T, King B, Christiana Boules, Beck K, Kegeles L, Purdon S, David A, McGuire P, Egerton A, and Author Group the 1H-MRS in Schizophrenia Investigators. Variability and Magnitude of Brain Glutamate Levels in Schizophrenia: A Meta And Mega-Analysis. Molecular Psychiatry. 2023 May;28(5):2039-2048. doi: 10.1038/s41380-023-01991-7.
• Kato Y, Yokokura M, Iwabuchi T, Murayama C, Harada T, Goto T, Tamayama T, Kameno Y, Wakuda T, Kuwabara H, Benner S, Senju A, Tsukada H, Nishizawa S, Ouchi Y, Yamasue H. Lower availability of mitochondrial complex I in anterior cingulate cortex of autism: a positron emission tomography study. The American Journal of Psychiatry. 2023 Apr 1;180(4):277-284. doi: 10.1176/appi.ajp.22010014.

2022

• Kuroda M, Kawakubo Y, Kamio Y, Yamasue H, Kono T, Nonaka M, Mastuda N, Kataoka M, Wakabayashi A, Yokoyama K, Kano Y, Kuwabara H*. Preliminary efficacy of cognitive-behavioral therapy on emotion regulation in adults with autism spectrum disorder: a pilot randomized waitlist-controlled study. PLOS ONE. 2022 Nov 23;17(11):e0277398. doi: 10.1371/journal.pone.0277398.
• Koike S, Sone M, Koshiyama D, Zhu Y, Maikusa N, Okada N, Yamasue H, Abe O, Kasai K. Structural brain abnormalities in schizophrenia patients with a history and presence of auditory verbal hallucination. Translational Psychiatry. 2022 Dec 22;12(1):511. doi: 10.1038/s41398-022-02282-5.
• Kushima I, Nakatochi M, Aleksic B, Okada T, Kimura H, Kato H, Morikawa M, Inada T, Ishizuka K, Torii Y, Nakamura Y, Tanaka S, Imaeda M, Takahashi N, Yamamoto M, Iw20amoto K, Nawa Y, Ogawa N, Iritani S, Hayashi Y, Lo T, Otgonbayar G, Furuta S, Iwata N, Ikeda M, Saito T, Ninomiya K, Okochi T, Hashimoto R, Yamamori H, Yasuda Y, Fujimoto M, Miura K, Itokawa M, Arai M, Miyashita M, Toriumi K, Kazutaka Ohi K, Shioiri T, Kitaichi K, Someya T, Watanabe Y, Egawa J, Takahashi T, Suzuki M, Sasaki T, Tochigi M, Nishimura F, Yamasue H, Kuwabara H, Wakuda T, Kato T, Kanba S, Horikawa H, Usami M, Kodaira M, Watanabe K, Yoshikawa T, Toyota T, Yokoyama S, Munesue T, Kimura R, Funabiki Y, Kosaka H, Jung M, Kasai K, Ikegame T, Jinde S, Numata S, Kinoshita M, Kato T, Kakiuchi C, Yamakawa K, Suzuki T, Hashimoto N, Ishikawa S, Yamagata B, Nio S, Murai T, Son S, Kunii Y, Yabe H, Inagaki M, Goto Y, Okumura Y, Ito T, Arioka Y, Mori D, Ozaki N. Cross-disorder analysis of genic and regulatory copy number variations in bipolar disorder, schizophrenia, and autism spectrum disorder. Biological Psychiatry. 2022 Sep 1;92(5):362-374.
• Zhu Y, Nakatani H, Yassin W, Maikusa N, Okada N, Kunimatsu A, Abe O, Kuwabara H, Yamasue H, Kasai K, Okanoya K, Koike S. Application of a machine learning algorithm for structural brain images in chronic schizophrenia to earlier clinical stages of psychosis and autism spectrum disorder: A multi-protocol imaging dataset study. Schizophrenia Bulletin. 2022 Mar 20;48(3): 563-574.
• Murayama C, Iwabuchi T, Kato Y, Yokokura M, Harada T, Goto T, Tamayama T, Kameno Y, Wakuda T, Kuwabara H, Senju A, Nishizawa S, Ouchi Y, Yamasue H*. Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study. Molecular Psychiatry. 2022 Apr; 27(4): 2106-2113 . doi: 10.1038/s41380-022-01464-3.
• Yamasue H, Kojima M, Kuwabara H, Kuroda M, Matsumoto K, Kanai C, Inada N, Owada K, Ochi K, Ono N, Benner S, Wakuda T, Kameno Y, Inoue J, Harada T, Tsuchiya K, Umemura K, Yamauchi A, Ogawa N, Kushima I, Ozaki N, Suyama S, Saito T, Uemura Y, Hamada J, Kano Y, Honda N, Kikuchi S, Seto M, Tomita H, Miyoshi N, Matsumoto M, Kawaguchi Y, Kanai K, Ikeda M, Nakamura I, Isomura S, Hirano Y, Onitsuka T, Kosaka H, Okada T. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: A randomised trial. Brain. 2022 Apr 18;145(2):490-499. doi: 10.1093/brain/awab291.
• Baldwin H, Radua J, Antoniades M, Haas SS, Frangou S, Agartz I, Allen P, Andreassen OA, Atkinson K, Bachman P, Baeza I, Bartholomeusz CF, Chee MWL, Colibazzi T, Cooper RE, Corcoran CM, Cropley VL, Ebdrup BH, Fortea A, Glenthøj LB, Hamilton HK, Haut KM, Hayes RA, He Y, Heekeren K, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Klaunig MJ, Koike S, Koppel A, Kristensen TD, Bin Kwak Y, Kwon JS, Lawrie SM, Lebedeva I, Lee J, Lin A, Loewy RL, Mathalon DH, Michel C, Mizrahi R, Møller P, Nelson B, Nemoto T, Nordholm D, Omelchenko MA, Pantelis C, Raghava JM, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Smigielski L, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Tang J, Theodoridou A, Thomopoulos SI, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TAMJ, Van Erp TGM, Waltz JA, Westlye LT, Wood SJ, Zhou JH, McGuire P, Thompson PM, Jalbrzikowski M, Hernaus D, Fusar-Poli P; ENIGMA Clinical High Risk for Psychosis Working Group. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis. Transl Psychiatry. 2022 Jul 26;12(1):297. doi: 10.1038/s41398-022-02057-y.

2021

• Zheng S, Masuda T, Matsunaga M, Noguchi Y, Ohtsubo Y, Yamasue H, Ishii K. Cultural Differences in Social Support Seeking: The Mediating Role of Empathic Concern. PLOS ONE. 2021 Dec 30 ;16(12):e0262001. doi: 10.1371/journal.pone.0262001. eCollection 2021.
• Matsunaga M, Ohtsubo Y, Masuda T, Noguchi Y, Yamasue H, Ishii K. A genetic variation in the Y chromosome among modern Japanese males is related to several physiological and psychological characteristics. Frontiers in Behavioral Neuroscience. 2021 Dec 2;15: 774879. doi: 10.3389/fnbeh.2021.774879
• Koike S, Fujioka M, Satomura Y, Koshiyama D, Tada M, Sakakibara E, Okada N, Takano Y, Iwashiro N, Natsubori T, Zhu Y, Abe O, Kirihara K, Yamasue H, Kasai K. Surface area in the left inferior frontal gyrus and insula was associated with 13- and 28-month clinical outcomes in ultra-high risk for psychosis and first-episode psychosis: a multi-modal neuroimaging investigation. npj Schizophrenia. 2021 Nov 29;7(1):56. DOI10.1038/s41537-021-00186-9.
• Sasabayashi D, Takayanagi Y, Takahashi T, Nishiyama S, Mizukami Y, Katagiri N, Tsujino N, Nemoto T, Sakuma A, Katsura M, Ohmuro N, Okada N, Tada M, Suga M, Maikusa N, Koike S, Furuichi A, Kido M, Noguchi K, Yamasue H, Matsumoto K, Mizuno M, Kasai K, Suzuki M. Reduced cortical thickness of the paracentral lobule in at-risk mental state individuals with poor 1-year functional outcomes. Translational Psychiatry. 2021 Jul 14;11(1):396.
• Morimoto C, Nakamura Y, Kuwabara H, Abe O, Kasai K, Yamasue H, Koike S. Unique Morphometric Features of the Cerebellum and Cerebellocerebral Structural Correlation between Autism Spectrum Disorder and Schizophrenia. Biological Psychiatry: Global Open Science. 2021 Sep;1(3):129-228.
• Morimoto C, Uematsu A, Nakatani H, Takano Y, Iwashiro N, Abe O, Yamasue H, Kasai K, Koike S. Volumetric Differences in Gray and White Matter of Cerebellar Crus I/II across the Different Clinical Stages of Schizophrenia. Psychiatry and Clinical Neurosciences. 2021 Aug;75(8):256-264.doi: 10.1111/pcn.13277.
• Inoue J, Matsuo K, Iwabuchi T, Takehara Y, Yamasue H*. How memory switches brain responses of patients with posttraumaticstress disorder. Cerebral Cortex Communications. 2021 Mar 20;2(2):tgab021. doi: 10.1093/texcom/tgab021. eCollection 2021.
• ENIGMA Clinical High Risk for Psychosis Working Group, Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, Fusar-Poli P, Uhlhaas PJ, Takahashi T, Sugranyes G, Kwak YB, Mathalon DH, Katagiri N, Hooker CI, Smigielski L, Colibazzi T, Via E, Tang J, Koike S, Rasser PE, Michel C, Lebedeva I, Hegelstad WTV, de la Fuente-Sandoval C, Waltz JA, Mizrahi R, Corcoran CM, Resch F, Tamnes CK, Haas SS, Lemmers-Jansen ILJ, Agartz I, Allen P, Amminger GP, Andreassen OA, Atkinson K, Bachman P, Baeza I, Baldwin H, Bartholomeusz CF, Borgwardt S, Catalano S, Chee MWL, Chen X, Cho KIK, Cooper RE, Cropley VL, Dolz M, Ebdrup BH, Fortea A, Glenthøj LB, Glenthøj BY, de Haan L, Hamilton HK, Harris MA, Haut KM, He Y, Heekeren K, Heinz A, Hubl D, Hwang WJ, Kaess M, Kasai K, Kim M, Kindler J, Klaunig MJ, Koppel A, Kristensen TD, Kwon JS, Lawrie SM, Lee J, León-Ortiz P, Lin A, Loewy RL, Ma X, McGorry P, McGuire P, Mizuno M, Møller P, Moncada-Habib T, Muñoz-Samons D, Nelson B, Nemoto T, Nordentoft M, Omelchenko MA, Oppedal K, Ouyang L, Pantelis C, Pariente JC, Raghava JM, Reyes-Madrigal F, Roach BJ, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Schiffman J, Schlagenhauf F, Schmidt A, Sørensen ME, Suzuki M, Theodoridou A, Tomyshev AS, Tor J, Værnes TG, Velakoulis D, Venegoni GD, Vinogradov S, Wenneberg C, Westlye LT, Yamasue H, Yuan L, Yung AR, van Amelsvoort TAMJ, Turner JA, van Erp TGM, Thompson PM, Hernaus D. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis. JAMA Psychiatry. 2021 Jul;78(7):753-766. doi:10.1001/jamapsychiatry.2021.0638.
• Merritt K, McGuire P K, Egerton A, Aleman A, Block W, Bloemen O J N, Borgan F, Bustillo J R, Capizzano A A, Coughlin J M, Fuente-Sandoval C, Demjaha A, Dempster K, Do Q K, Du F, Falkai P, Galinska-Skok B, Gallinat J, Gasparovic C, Ginestet C E, Goto N, Graff-Guerrero A, Choon Ho B, Howes D O, Jauha S, Jeon P, Kato T, Kaufmann C A, Kegeles L S, Keshavan M, Kim S Y, Kunugi H, Lauriello J, Liemburg E J, Mcilwain M E, Modinos G, Mouchlianitis E D, Nakamura J, Nenadic I, Dost Ö, Ota M, Palaniyappan L, Pantelis C, Plitman E, Posporelis S, Purdon S E, Reichenbach J R, Renshaw P F, Russell B R, Sawa A, Schaefer M, Shungu D C, Smesny S, Stanley J A, Stone J M, Szulc A, Taylor R, Thakkar K, Théberge J, Tibbo P G, Amelsvoort T, Walecki J, Williamson P C, Wood J S, Xin L, Yamasue H. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. JAMA Psychiatry. 2021 Apr 21;78(6):667-681. doi: 10.1001/jamapsychiatry.2021.0380.
• Kato Y, Kuwabara H, Okada T, Munesue T, Benner S, Kuroda M, Kojima M, Yassin W, Eriguchi Y, Kameno Y, Murayama C, Nishimura T, Tsuchiya K, Kasai K, Ozaki N, Kosaka H, Yamasue H*. Oxytocin-induced increase in N,N-dimethylglycine and time-course of changes in oxytocin efficacy for autism social core symptoms. Molecular Autism. 2021 Feb 23;12(1):15. doi: 10.1186/s13229-021-00423-z.
• Wakuda T, Sakurai A, Yoshida R, Yamasue H. Late-onset oligosymptomatic myotonic dystrophy type 1 mimicking prodromal dementia with Lewy bodies. American Journal of Geriatric Psychiatry. 2021 Sep;29(9):982-983. doi: 10.1016/j.jagp.2021.01.011.
• Kato Y, Kuwabara H, Okada T, Munesue T, Benner S, Kuroda M, Kojima M, Yassin W, Eriguchi Y, Kameno Y, Murayama C, Nishimura T, Tsuchiya K, Kasai K, Ozaki N, Kosaka H, Yamasue H*. Oxytocin-induced increase in N,N-dimethylglycine and time-course of changes in oxytocin efficacy for autism social core symptoms. Molecular Autism. 2021 Feb 23;12(1):15. doi: 10.1186/s13229-021-00423-z.
• Wakuda T, Sakurai A, Yoshida R, Yamasue H. Late-onset oligosymptomatic myotonic dystrophy type 1 mimicking prodromal dementia with Lewy bodies. American Journal of Geriatric Psychiatry. 2021 Sep;29(9):982-983. doi: 10.1016/j.jagp.2021.01.011.
• Yokokura M, Takebayashi K, Takao A, Nakaizumi K, Yoshikawa E, Futatsubashi M, Suzuki K, Nakamura K, Yamasue H, Ouchi Y. In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: A positron emission tomography study. Molecular Psychiatry. 2021 Sep;26(9):4958-4967. doi: 10.1038/s41380-020-0784-7.
• Takao Nozaki, Kenji Sugiyama, Tetsuya Asakawa, Hiroki Namba, Masamichi Yokokura, Tatsuhiro Terada, Tomoyasu Bunai, Yasuomi Ouchi. Increased anteroventral striatal dopamine transporter and motor recovery after subthalamic deep brain stimulation in Parkinson's disease. Journal of neurosurgery, 1-11, Dec 31, 2021
• Tomoo Inubushi, Masanori Ito, Yutaro Mori, Masami Futatsubashi, Kengo Sato, Shigeru Ito, Masamichi Yokokura, Tomomi Shinke, Yosuke Kameno, Akihiro Kakimoto, Toshihiko Kanno, Hiroyuki Okada, Yasuomi Ouchi, Etsuji Yoshikawa. Neural correlates of head restraint: Unsolicited neuronal activation and dopamine release. NeuroImage, 224 117434-117434, Jan 1, 2021
  
  

2020

• Sakurai A, Wakuda T*, Yoshida R, Katoh S, Yamasue H. Successful discontinuation of oxycodone under pramipexole treatment for restless legs syndrome due to withdrawal. Psychiatry and Clinical Neurosciences. 2021 Mar;75(3):112-113. doi: 10.1111/pcn.13184. Epub 2020 Dec 22.
• Kameno Y, Hanada A, Asai D, Naito Y, Kuwabara H, Enomoto N, Yamasue H*. Individual psychotherapy using psychological first aid for frontline nurses at high risk of psychological distress during the COVID-19 pandemic. Psychiatry and Clinical Neurosciences. 2021 Jan;75(1):25-27. doi: 10.1111/pcn.13170. Epub 2020 Nov 13.
• Zheng S, Masuda T, Matsunaga M, Noguchi Y, Ohtsubo Y, Yamasue H, Ishii K. Oxytocin Receptor Gene (OXTR) and Childhood Adversity Influence Trust. Psychoneuroendocrinology. 2020 Nov;121:104840. doi: 10.1016/j.psyneuen.2020.104840. Epub 2020 Aug 18.
• Yassin W, Nakatani H, Zhu Y, Kojima M, Owada K, Kuwabara H, Gonoi W, Aoki Y, Takao H, Natsubori T, Iwashiro N, Kasai K, Kano Y, Abe O, Yamasue H*, Koike S*. Machine learning classification using neuroimaging data in schizophrenia, autism, ultra-high risk and first episode psychosis. Translational Psychiatry. 2020 Aug 17;10(1):278. doi: 10.1038/s41398-020-00965-5.
• Ikegame T, Bundo M, Okada N, Murata Y, Koike S, Sugawara H, Saito T, Ikeda M, Owada K, Fukunaga M, Yamashita F, Koshiyama D, Natsubori T, Iwashiro N, Asai T, Yoshikawa A, Nishimura F, Kawamura Y, Ishigooka J, Kakiuchi C, Sasaki T, Abe O, Hashimoto R, Iwata N, Yamasue H, Kato T, Kasai K, Iwamoto K. Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia. Schizophrenia Bulletin. 2020 Dec 1;46(6):1577-1586. doi: 10.1093/schbul/sbaa075.
• Schmidt A, Davies C, Paloyelis Y, Meyer N, Micheli A, Ramella-Cravaro V, provenzani U, Aoki Y, Rutigliano G, Cappucciati M, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, Williams S, Taylor D, Borgwardt S, Yamasue H, McGuire P, Paolo Fusar-Poli P. Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis. Translational Psychiatry. 2020 Jun 22;10(1):203. doi: 10.1038/s41398-020-00885-4.
• Sasabayashi D, Takayanagi Y, Takahashi T, Katagiri N, Sakuma A, Obara C, Katsura M, Okada N, Koike S, Yamasue H, Nakamura M, Furuichi A, Kido M, Nishikawa Y, Noguchi K, Matsumoto K, Mizuno M, Kasai K, Suzuki M. Subcortical brain volume abnormalities in individuals with an at-risk mental state. Schizophrenia Bulletin. 2020 Jul 8;46(4):834-845. doi: 10.1093/schbul/sbaa011.
• Nemoto K, Shimokawa T, Fukunaga M, Yamashita F, Tamura M, Yamamori H, Yasuda Y, Azechi H, Kudo N, Watanabe Y, Kido M, Takahashi T, Koike S, Okada N, Hirano Y, Onitsuka T, Yamasue H, Suzuki M, Kasai K, Hashimoto R, Arai T. Differentiation of schizophrenia using structural MRI with consideration of scanner differences: A real-world multi-site study. Psychiatry and Clinical Neurosciences. 2020 Jan;74(1):56-63. doi: 10.1111/pcn.12934.
• Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Usui K, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Azechi H, Watanabe Y, Hashimoto N, Narita H, Kusumi I, Ohi K, Shimada T, Kataoka Y, Yamamoto M, Ozaki N, Okada G, Okamoto Y, Harada K, Matsuo K, Yamasue H, Abe O, Hashimoto R, Takahashi T, Hori T, Nakataki M, Onitsuka T, Holleran L, Jahanshad N, van Erp T, Turner J, Donohoe G, Thompson P, Kasai K, Hashimoto R. White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals. Molecular Psychiatry. 2020 Apr;25(4):883-895. doi: 10.1038/s41380-019-0553-7.
• Noriyoshi Usui, Keiko Iwata, Taishi Miyachi, Shu Takagai, Keisuke Wakusawa, Takahiro Nara, Kenji J Tsuchiya, Kaori Matsumoto, Daisuke Kurita, Yosuke Kameno, Tomoyasu Wakuda, Kiyokazu Takebayashi, Yasuhide Iwata, Toru Fujioka, Takaharu Hirai, Manabu Toyoshima, Tetsuo Ohnishi, Tomoko Toyota, Motoko Maekawa, Takeo Yoshikawa, Masato Maekawa, Kazuhiko Nakamura, Masatsugu Tsujii, Toshiro Sugiyama, Norio Mori, Hideo Matsuzaki. VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction. EBioMedicine, 58 102917-102917, Aug, 2020
• Aki Hirayama, Keisuke Wakusawa, Toru Fujioka, Keiko Iwata, Noriyoshi Usui, Daisuke Kurita, Yosuke Kameno, Tomoyasu Wakuda, Shu Takagai, Takaharu Hirai, Takahiro Nara, Hiromu Ito, Yumiko Nagano, Shigeru Oowada, Masatsugu Tsujii, Kenji J. Tsuchiya & Hideo Matsuzaki. Simultaneous evaluation of antioxidative serum profiles facilitates the diagnostic screening of autism spectrum disorder in under-6-year-old children. Scientific reports, 10(1) 20602-20602, Nov 26, 2020
• Takashi Matsudaira, Tatsuhiro Terada, Tomokazu Obi, Masamichi Yokokura, Yukitoshi Takahashi, Yasuomi Ouchi. Coexistence of cerebral hypometabolism and neuroinflammation in the thalamo-limbic-brainstem region in young women with functional somatic syndrome. EJNMMI research, 10(1) 29-29, Mar 20, 2020
  
  

2019

• Ochi K, Ono N, Owada K, Kojima M, Kuroda M, Sagayama S, Yamasue H*. Quantization of speech and synchrony in the conversation of adults with autism spectrum disorder. PLOS ONE. 2019 Dec 5;14(12):e0225377. doi: 10.1371/journal.pone.0225377. eCollection 2019.
• Ohtsubo Y, Masuda T, Matsunaga M, Noguchi Y, Yamasue H, Ishii K. Is Collectivistic Forgiveness Different from Individualistic Forgiveness? Dispositional Correlates of Trait Forgivingness in Canada and Japan. Canadian Journal of Behavioural Science. 2019;51(4):290-295.
• Yassin W, Kojima M, Owada K, Kuwabara H, Gonoi W, Aoki Y, Takao H, Natsubori T, Iwashiro N, Kasai K, Kano Y, Abe O, Yamasue H*. Paternal age contribution to brain white matter aberrations in autism spectrum disorder. Psychiatry and Clinical Neurosciences. 2019 Oct;73(10):649-659. doi: 10.1111/pcn.12909.
• Yokokura M, Terada T, Bunai T, Nakaizumi K, Kato Y, Yoshikawa E, Futatsubashi M, Suzuki K, Yamasue H, Ouchi Y. Alterations in serotonin transporter and body image-related cognition in anorexia nervosa. NeuroImage: Clinical. 2019;23:101928. doi: 10.1016/j.nicl.2019.101928.
• Owada K, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, Matsumoto K, Kuwabara H, Mori D, Okamoto Y, Yoshimura Y, Kawakubo Y, Arioka Y, Kojima M, Yuhi T, Yassin W, Kushima I, Benner S, Ogawa N, Kawano N, Eriguchi Y, Uemura Y, Yamamoto M, Kano Y, Kasai K, Higashida H, Ozaki N, Kosaka H, Yamasue H*. Quantitative facial expression analysis revealed the efficacy and time-course of oxytocin in autism. Brain. 2019 July;142:2127-2136. pii: awz126. doi: 10.1093/brain/awz126.
• Higashida H, Munesue T, Kosaka H, Yamasue H, Yokoyama S, Kikuchi M. Social Interaction Improved by Oxytocin in the Subclass of Autism with Comorbid Intellectual Disabilities. Diseases. 2019 Feb 22;7(1).
• Iwashiro N, Takano Y, Natsubori T, Aoki Y, Yahata N, Gonoi W, Kunimatsu A, Abe O, Kasai K, Yamasue H*. Aberrant attentive and inattentive brain activity to auditory negative words, and its relation to persecutory delusion in patients with schizophrenia. Neuropsychiatr Dis Treat. 2019 Feb 14;15:491-502.
• Wakuda T, Suzuki A, Hasegawa M, Ichikawa D, Yamasue H. Acute agranulocytosis when switching from risperidone to paliperidone. Australian and New Zealand Journal of Psychiatry. 2019 Jun;53(6):586-587. doi: 10.1177/0004867418821441.

2018（*責任著者）

• Yamasue H*, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, Matsumoto K, Kuwabara H, Mori D, Okamoto Y, Yoshimura Y, Kawakubo Y, Arioka Y, Kojima M, Yuhi T, Owada K, Yassin W, Kushima I, Benner S, Ogawa N, Eriguchi Y, Kawano N, Uemura Y, Yamamoto M, Kano Y, Kasai K, Higashida H, Ozaki N, Kosaka H. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: A randomized clinical trial. Mol Psychiatry. 2018 Jun 29. doi: 10.1038/s41380-018-0097-2. [Epub ahead of print].
• Benner S, Aoki Y, Watanabe T, Endo N, Abe O, Kuroda M, Kuwabara H, Kawakubo Y, Takao H, Kunimatsu A, Kasai K, Bito H, Kakeyama M, Yamasue H: Neurochemical evidence for differential effects of acute and repeated oxytocin administration, Mol Psychiatry, 2018. [Epub ahead of print]
• Matsunaga M, Masuda T, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H. Culture and cannabinoid receptor gene polymorphism interact to influence the perception of happiness. PLoS One. 2018 Dec 21;13(12):e0209552. doi: 10.1371/journal.pone.0209552.
• Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, Morikawa M, Ishizuka K, Shiino T, Kimura H, Arioka Y, Yoshimi A, Takasaki Y, Yu Y, Nakamura Y, Yamamoto M, Iidaka T, Iritani Shuji, Inada T, Ogawa N, Shishido E, Torii Youta, Kawano N, Omura Y, Yoshikawa T, Uchiyama T, Yamamoto T, Ikeda M, Hashimoto R, Yamamori H, Yasuda Y, Someya T, Watanabe Y, Egawa J, Nunokawa A, Itokawa M, Arai M, Miyashita M, Kobori A, Suzuki M, Takahashi T, Usami M, Kodaira M, Watanabe K, Sasaki T, Kuwabara H, Tochigi M, Nishimura F, Yamasue H, Eriguchi Y, Benner S, Kojima M, Yassin W, Munesue T, Yokoyama S, Kimura R, Funabiki Y, Kosaka H, Ishitobi M, Ohmori T, Numata S, Yoshikawa T, Toyota T, Yamakawa K, Suzuki T, Inoue Y, Nakaoka K, Goto Y, Inagaki M, Hashimoto N, Kusumi I, Son S, Murai T, Ikegame T, Okada N, Kasai K, Kunimoto S, Mori D, Iwata N, Ozaki N. Comparative analyses of copy number variation in autism spectrum disorder and schizophrenia reveal etiological overlap and biological insights. Cell Reports. 9th Aug 2018 accepted
• Ikeda M, Takahashi A, Kamatani Y, Momozawa Y, Saito T, Kondo K, Shimasaki A, Kawase K, Sakusabe T, Iwayama Y, Toyota T, Wakuda T, Kikuchi M, Kanahara N, Yamamori H, Yasuda Y, Watanabe Y, Hoya S, Aleksic B, Kushima I, Arai H, Takaki M, Hattori K, Kunugi H, Okahisa Y, Ohnuma T, Ozaki N, Someya T, Hashimoto R, Yoshikawa T, Kubo M, Iwata N. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect. Schizophr Bull. Oct 3. doi: 10.1093/schbul/sby140. 2018.
• Kojima M, Yassin W, Owada K, Aoki Y, Kuwabara H, Natsubori T, Iwashiro N, Gonoi W, Takao H, Kasai K, Abe O, Kano Y, Yamasue H*. Neuroanatomical Correlates of Advanced Paternal and Maternal Age at Birth in Autism Spectrum Disorder. Cereb Cortex. 2018 May 25. doi: 10.1093/cercor/bhy122. [Epub ahead of print]
• Benner S, Yamasue H*. Clinical potential of oxytocin in autism spectrum disorder: current issues and future perspectives. Behav Pharmacol. 2018 Feb;29(1):1-12.
• Yamasue H*, Domes G. Oxytocin and Autism Spectrum Disorders. Curr Top Behav Neurosci. 2017 Aug 2.
• Nakaizumi K, Ouchi Y, Terada T, Yoshikawa E, Kakimoto A, Isobe T, Bunai T, Yokokura M, Suzuki K, Magata Y.: In vivo depiction of α7 nicotinic receptor loss for cognitive decline in Alzheimer's disease. J Alzheimers Dis. 61(4):1355-1365, 2018.
• Bunai T, Terada T, Kono S, Yokokura M, Yoshikawa E, Futatsubashi M, Miyajima H, Ouchi Y.: Neuroinflammation following disease modifying therapy in multiple sclerosis: A pilot positron emission tomography study. J Neurol Sci. 15;385:30-33, 2018.
• Owada K, Kojima M, Yassin W, Kuroda M, Kawakubo Y, Kuwabara H, Kano Y, Yamasue H*. Computer-analyzed facial expression as a surrogate marker for autism spectrum social core symptoms. PLoS One. 2018 Jan 2;13(1):e0190442.
• Nakamura M, Takahashi T, Takayanagi Y, Sasabayashi D, Katagiri N, Sakuma A, Obara C, Koike S, Yamasue H, Furuichi A, Kido M, Nishikawa Y, Noguchi K, Matsumoto K, Mizuno M, Kasai K, Suzuki M.Surface morphology of the orbitofrontal cortex in individuals at risk of psychosis: a multicenter study. Eur Arch Psychiatry Clin Neurosci. 2018 Mar 23.

2017

• Matsunaga M, Kawamichi H, Umemura T, Hori R, Shibata E, Kobayashi F, Suzuki K, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H, Ohira H. Neural and Genetic Correlates of the Social Sharing of Happiness. Front Neurosci. 2017;11:718.
• Sasabayashi D, Takayanagi Y, Takahashi T, Koike S, Yamasue H, Katagiri N, Sakuma A, Obara C, Nakamura M, Furuichi A, Kido M, Nishikawa Y, Noguchi K, Matsumoto K, Mizuno M, Kasai K, Suzuki M. Increased occipital gyrification and development of psychotic disorders in individuals with an at-risk mental state: a multicenter study. Biological Psychiatry, 2017;82:737-745.
• Matsunaga M, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H. Association between salivary serotonin and the social sharing of happiness. PLOS ONE, 2017;12(7):e0180391.
• Hashimoto N, Ito YM, Okada N, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Takemura A, Son S, Narita H, Yamamoto M, Tha KK, Katsuki A, Ohi K, Yamashita F, Koike S, Takahashi T, Nemoto K, Fukunaga M, Onitsuka T, Watanabe Y, Yamasue H, Suzuki M, Kasai K, Kusumi I, Hashimoto R. The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects. Neuroimage Clin. 2017;17:563-569.
• Paparelli A, Iwata K, Wakuda T, Iyegbe C, Murray RM, Takei N. Perinatal Asphyxia in Rat Alters Expression of Novel Schizophrenia Risk Genes. Front Mol Neurosci. 10:341, 2017.
• Fukai M, Hirosawa T, Kikuchi M, Ouchi Y, Takahashi T, Yoshimura Y, Miyagishi Y, Kosaka H, Yokokura M, Yoshikawa E, Bunai T, Minabe Y.: Oxytocin effects on emotional response to others' faces via serotonin system in autism: A pilot study. Psychiatry Res. Jun 28;267:45-50, 2017
• Balan S, Kameno Y: Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia., Schizophr Res., 185, 33-40. 2017.
• 望月洋介，奈良岡悠己，井上淳，高貝就，星野良一：追体験入院の適切な運用方法構築のための基礎的研究，メンタルヘルス岡本記念財団研究助成報告集28，137-141，2017．
• Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, Yoshikawa E, Futatsubashi M, Suzuki K, Mori N, Ouchi Y: Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C]DPA713 versus [11C](R)PK11195. J Cereb Blood Flow Metab 37(3): 877-889, 2017.
• Takano Y, Aoki Y, Yahata N, Kawakubo Y, Inoue H, Iwashiro N, Natsubori T, Koike S, Gonoi W, Sasaki H, Takao H, Kasai K, Yamasue H*. Neural basis for inferring false beliefs and social emotions in others among individuals with schizophrenia and those at ultra-high risk for psychosis. Psychiatry Research: Neuroimaging 2017; 259:34-41.
• Watanabe T, Otowa T, Abe O, Kuwabara H, Aoki Y, Natsubori T, Takao H, Kakiuchi C, Kondo K, Ikeda M, Iwata N, Kasai K, Sasaki T, Yamasue H*. Oxytocin receptor gene variations predict neural and behavioral response to oxytocin in autism. Social Cognitive and Affective Neuroscience 2017;12(3):496-506.
• Balan S, Yamada K, Iwayama Y, Hashimoto T, Toyota T, Shimamoto C, Maekawa M, Takagai S, Wakuda T, Kameno Y, Kurita D, Yamada K, Kikuchi M, Hashimoto T, Kanahara N, Yoshikawa T. Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia. Schizophr Res.pii: S0920-9964(17)30003-8. 2017.
• Hirosawa T, Kikuchi M, Ouchi Y, Takahashi T, Yoshimura Y, Kosaka H, Furutani N, Hiraishi H, Fukai M, Yokokura M, Yoshikawa E, Bunai T, Minabe Y: A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder. Autism Res. 2017 Mar 7 [Epub ahead of print]
  
  

2016

• Kameno Y, Suzuki K, Takagai S, Iwata K, Matsuzaki H, Takahashi K, Wakuda T, Iwata Y, Magata Y, Mori N: Mismatch in cerebral blood flow and glucose metabolism after the forced swim stress in rats., Acta Neuropsychiatr, 28, 6, 352-356, 2016.
• Terada T, Yokokura M, Yoshikawa E, Futatsubashi M, Kono S, Konishi T, Miyajima H, Hashizume T, Ouchi Y: Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study. Ann Nucl Med 30(8): 579-587, 2016
• Kosaka H, Okamoto Y, Munesue T, Yamasue H, Inohara K, Fujioka T, Anme T, Orisaka M, Ishitobi M, Jung M, Fujisawa T, Tanaka S, Arai S, Asano M, Saito D, Sadato N, Tomoda A, Omori M, Sato M, Okazawa H, Higashida H, Wada Y. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: A 24-week randomized clinical trial. Transl Psychiatry 2016;6(8):e872.
• Okada N, Fukunaga M, Yamashita F, Koshiyama D, Yamamori H, Isobe M, Isomura S, Natsubori T, Narita H, Hashimono N, Miyata J, Koike S, Takahashie T, Yamasue H, Matsuo K, Onitsuka T, Iidaka T, Kawasaki Y, Yoshimura R, Watanabe Y, Suzuki M, Turner JA, Takeda M, Thompson PM, Osaki N, Kasai K, Hashimoto R. Abnomal asymmertries in subcorticl brain volume in schizophrenia. Mol Psychiatry. 2016;21(10):1460-6.
• Fujioka T, Inohara K, Okamoto Y, Masuya Y, Ishitobi M, Saito DN, Jung M, Arai S, Matsumura Y, Fujisawa TX, Narita K, Suzuki K, Tsuchiya KJ, Mori N, Katayama T, Sato M, Munesue T, Okazawa H, Tomoda A, Wada Y, Kosaka H*: Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults, Mol Autism, 7:19, 2016.
• Nishimura T, Takei N*, Tsuchiya KJ, Asano R, Mori N: Identification of neurodevelopmental trajectories in infancy and of risk factors affecting deviant development: a longitudinal birth cohort study, Int J Epidemiol, pii:dyv363, 2016.
• Liu X, Shimada T, Otowa T, Wu YY, Kawamura Y, Tochigi M, Iwata Y, Umekage T, Toyota T, Maekawa M, Iwayama Y, Suzuki K, Kakiuchi C, Kuwabara H, Kano Y, Nishida H, Sugiyama T, Kato N, Chen CH, Mori N, Yamada K, Yoshikawa T, Kasai K, Tokunaga K, Sasaki T*, Gau SS*: Genome-wide association study of autism spectrum disorder in the east asian populations, Autism Res, 9:340-349, 2016.
• Tang Y, Han S, Asakawa T, Luo Y, Han X, Xiao B, Dong Q, Lu C, Wang L*: Effects of intracerebral hemorrhage on 5-hydroxymethylcytosine modification in mouse brain, Neuropsychiatr Dis Treat, 12:617-624, 2016.

総説

2025

• Yamasue H. New finding of brain molecular mechanisms of obsessive-compulsive disorder may uncover those of treatment-resistant cases. Psychiatry Clin Neurosci. 2025 Feb;79(2):47. doi: 10.1111/pcn.13765.
  
  

2024

• Yamasue H. Is the efficacy of oxytocin for autism diminished at higher dosages or repeated doses? Potential mechanisms and candidate solutions Peptides. 2024 Jan:171:171133. doi: 10.1016/j.peptides.2023.171133.
• 山末英典: 巻頭言「NEURO2024（第46回日本生物学的精神医学会年会）の開催にあたって」日本生物学的精神医学会誌 35(2):60, 2024.
• 山末英典: 「性差と自閉スペクトラム症」精神医学 66(1):45-50, 2024　特集「性差と精神医学―なぜ頻度や重症度に差があるのか」
  
  

2023

• 山末英典: 「オキシトシン経鼻投与の応用による自閉スペクトラム症中核症状治療薬の開発」医学のあゆみ　Vol.286 (2): 149-152, 2023.
• 山末英典: 「医師主導ランダム化比較試験のポイント：自閉スペクトラム症中核症状に対する初の治療薬開発の試み」精神医学 65(1):71-78, 2023.
  
  

2022

• 山末英典: 「自閉スペクトラム症の脳画像的特徴とその臨床応用の可能性」精神科治療学　37巻11号　2022.
• 山末英典: 「社会認知機能障害の新規治療薬開発」精神科　41(5): 677-686, 2022　特集1「社会認知とは」.
• 山末英典: 「自閉スペクトラム症と注意欠如・多動症の脳画像研究」Clinical Neuroscience 40(3):304-307, 2022.
• 村山 千尋, 尾内 康臣, 千住 淳, 山末 英典: 「自閉スペクトラム症のPET研究最前線　D2/3ドーパミン受容体と脳機能」子どものこころと脳の発達(2185-1417)13巻1号 Page18-24(2022.10).
  
  

2021

• 山末英典: 「社会的コミュニケーションの障害の客観定量評価　－自閉スペクトラム症中核状に対する初の治療薬を開発するために－」Japanese Journal of Child and Adolescent Psychiatry 児童青年精神医学とその近接領域　62(4):13-18, 2021.
• 山末英典: 「自閉スペクトラム症」CLINICAL NEUROSCIENCE 39(8): 1028-1029, 2021 中外医学社.
• 山末英典, Walid Yassin, 児島正樹: 「自閉スペクトラム症における両親の高齢化と脳形態特徴の関係」精神神経学雑誌 123(1): 3-10, 2021.
  
  

2020

• Yamasue H*, Sugiyama K. Application of Deep Brain Stimulation for Treatment-Resistant Obsessive Compulsive Disorder: Current Status and Future Perspectives in Japan. Neurologia medico-chirurgica 2020 Oct 16. doi: 10.2176/nmc.ra.2020-0196.
• 山末英典: 「オキシトシンによる自閉スペクトラム症中核症状への治療薬開発」Japanese Journal of Child and Adolescent Psychiatry 児童青年精神医学とその近接領域　61(3):263-268, 2020.
• 山末英典: 「社会的コミュニケーションの障害の客観定量評価」精神科臨床 Legato 6(3): 30-33(150-153) , メディカルレビュー社, 2020.12.1
• 山末英典: 「オキシトシンを鍵分子とした基礎臨床研究の統合：脳画像から治療薬開発へ」日本生物学的精神医学会誌31(2): 85-89, 2020.
• 山末英典: 「強迫性障害に対する深部脳刺激」臨床精神医学 49 (6): 797-800 , 2020.
• 山末英典: 「新時代の森田療法、来たるべきもの〜臨床試験による効果検証と脳画像解析による効果発現メカニズムの検討〜」日本森田療法学会雑誌 31: 1-4 , 2020.
• 山末英典: 「自閉スペクトラム症へのオキシトシン経鼻スプレー」ドクターサロン 64 (5): 9-16 , 2020.
• 山末英典: 「オキシトシン治療で表情が豊かに〜自閉スペクトラム症の改善効果とその経時変化〜」医学のあゆみ 273(12): 1169-1170, 2020.
• 亀野陽亮、山末英典: 「うつ病に対する経頭蓋直流電気刺激法：有効性と安全性」〈講座 精神疾患の臨床〉「気分障害(気分症)」452-456, 2020.
• 山末英典、杉山憲嗣: 「治療抵抗性うつ病に対する脳深部刺激術：有効性と安全性」〈講座 精神疾患の臨床〉「気分障害(気分症)」457-461, 2020.
  
  

2019

• Yamasue H*, Aran A, Berry-Kravis E. Emerging pharmacological therapies in fragile X syndrome and autism. Current Opinion in Neurology 2019 Aug;32(4):635-640. doi: 10.1097/WCO.0000000000000703.
• 山末英典: 「新規な自閉スペクトラム症中核症状治療薬の開発」Pharma Medica 37 (8): 47-50 , 2019.
• 山末英典: 「社会性の障害を表す客観定量化した自閉症的表情特徴とそれに対するオキシトシン治療効果の経時変化」生物学的精神医学会誌30 (4): 168-172, 2019
• 山末英典: 「自閉スペクトラム症の薬物療法について」Modern Physician 39 (12): 1131-1132 , 2019.
• 山末英典: 「新規な自閉スペクトラム症中核症状治療薬の開発〜臨床試験、脳画像解析、遺伝子解析の統合的アプローチ〜」BRAIN and NERVE 71 (9): 971-980, 2019
• 山末英典: 「マルチモダリティ脳画像解析とオキシトシンを応用した自閉スペクトラム症中核症状に対する治療薬開発」医学のあゆみ279 (9): - , 2019.
• 山末英典: 「臨床試験による自閉症のオキシトシン仮説の検証」精神科治療学34 (9): 1059-1064, 2019.
• 山末英典: 「新規な自閉スペクトラム症中核症状治療薬の開発〜オキシトシンを軸とした臨床試験、脳画像解析、遺伝子解析の統合〜」精神科35 (3): - , 2019.
• 山末英典: 社会的コミュニケーションの障害の客観定量化, 分子精神医学19 (2): 2-6, 2019.
• 山末英典: 新規な自閉スペクトラム症中核症状治療薬の開発〜オキシトシンを軸とした基礎と臨床の融合〜, 神経内科90 (3): 263-260, 2019.
• 山末英典: 自閉スペクトラム症に対するオキシトシン投与効果の検討における進展, 医学のあゆみ268 (3): 204-207, 2019.
• 桑原斉、池谷和: 発達障害と合理的配慮、育ちの科学、32、66-71、2019.
  
  

2018

• 山末英典「自閉スペクトラム症に対するオキシトシン治療効果の医師主導 Randomized Controlled Trial －マルチモダリティ脳画像解析の応用－」生物学的精神医学会誌29: 109-113, 2018
• 桑原斉、池谷和：犯罪・触法行為と自閉スペクトラム症、児童青年精神医学とその近接領域、59、148-158、2018
• 池谷和、桑原斉、高貝就：ASDの過剰診断を防ぐために、精神科、33、257-261、2018
• 山末英典: オキシトシン受容体遺伝子, 分子精神医学18: 47-49, 2018
• 山末英典: オキシトシンと社会脳、自閉症, 生体の科学69: 73-76, 2018
• 山末英典: 自閉スペクトラム症中核症状に対するオキシトシン治療〜マルチモダリティ脳画像解析とゲノム薬理学の応用〜, 臨床精神医学47: 275-281, 2018
• 栗田大輔, 竹林淳和: 神経性やせ症に対する包括的入院治療プログラム―静岡県摂食障害診療ネットワークの構築―, 日本精神神経学会誌, 120, 85-92, 2018
• Seico Benner, Yamasue H*. Clinical Potential of Oxytocin in Autism Spectrum Disorder: Current Issues and Future Perspectives. Behavioral Pharmacology, Behav Pharmacol. 2018 Feb;29(1):1-12.

2017

• Yamasue H*, Domes G*. Oxytocin and Autism Spectrum Disorders. Curr Top Behav Neurosci. 2017 Aug 2.
• 山末英典: マルチモダリティ脳画像解析による自閉スペクトラム症中核症状に対するオキシトシン経鼻剤の効果判定, 教育と医学 772: 67-73, 2017年10月号
• 山末英典: オキシトシンとマルチモダリティ脳画像解析を応用した自閉スペクトラム症中核症状に対する治療薬開発, 分子精神医学17(4): 15-21, 2017.
• 山末英典: 自閉スペクトラム症中核症状に対する治療薬開発〜オキシトシン経鼻剤とマルチモダリティ脳画像解析の応用〜, 臨床精神薬理20巻6号:621-628, 2017.
• 山末英典: 自閉スペクトラム症におけるオキシトシンの効果, 日本医師会雑誌 145(11):2372, 2017.
• 山末英典: 自閉スペクトラム症のVoxel Based Morphometry, BRAIN and NERVE 69(5): 529-538, 2017.
• 山末英典: 自閉スペクトラム症へのオキシトシン治療の可能性〜自主臨床試験へのマルチモダリティ脳画像解析の応用〜, 発達障害医学の進歩29集;55-62, 2017.
• 山末英典: 自閉スペクトラム症へのオキシトシン治療の可能性, ＪＬＮＥＷＳ（日本発達障害連盟ニュース）113: 7, 2017.
• 山末英典: 精神症状の客観定量化-表出と内的処理過程の乖離-, 最新精神医学 22(2): 79「巻頭言」, 2017.
• 山末英典: 巻頭言-精神疾患研究における「必要性」について-精神医学 59(2):104-105, 2017.
• 和久田智靖: 抗NMDA受容体脳炎に見られる精神症状と不随意運動の治療アプローチ, 臨床精神薬理, 20巻4号, 399-406, 2017.
• 栗田大輔: 女性の摂食障害のケア, 産婦人科の実際, 66巻,293-298,2017
• 望月洋介: 臥褥再考　その意義と補完　浜松医科大学における臥褥の意義と補完，日本森田療法学会雑誌28（1），45-49，2017．
  
  

2016

• 山末英典: オキシトシン点鼻薬の自閉スペクトラム症に対する臨床応用 内分泌 糖尿病 代謝内科 43(1):73-78, 2016.
• 山末英典: 脳画像で精神疾患の何が分かるのか, 精神科臨床Legato 2(4):20-25, 2016.
• Asakawa T, Fang H, Sugiyama K, Nozaki T, Hong Z, Yang Y, Hua F, Ding G, Chao D, Fenoy AJ, Villarreal SJ, Onoe H, Suzuki K, Mori N, Namba H, Xia Y: Animal behavioral assessments in current research of Parkinson's disease, Neurosci Biobehav Rev, 65:63-94, 2016.
• 竹林淳和: 【摂食障害の治療update】摂食障害治療支援センター, 精神科, 28:40-45, 2016.

2023

• 山末英典：「付録：精神科臨床実習の手引き」標準精神医学［第9版］、医学書院、2023、pp
• 山末英典：「糖尿病・内分泌代謝科」自閉スペクトラム症とオキシトシン経鼻剤、科学評論社、2023、56（5）：630-637
  
  

2022

• 山末英典：「精神医学の基盤」自閉スペクトラム症中核症状に対する初の治療薬開発の試み：オキシトシン経鼻剤の自主臨床試験と医師主導治験、学樹書院、2022、6 (1)、123-131．
• 山末英典：「自閉スペクトラム症」精神科専門医テキスト、2022.
  
  

2021

• 山末英典：「ニュートン式 超図解 最強にわかる‼　精神の病気」、ニュートンプレス、2021.
• 山末英典：「こころの病気と脳」Newton別冊『脳とは何か』改訂第2版、ニュートンプレス、2021、pp108-133.
• 山末英典：「多職種連携を支える「発達障害」理解　―ASD・ADHDの今を知る旅」『第7章　ASD/ADHDの脳科学：脳の特徴』、北大路書房、2021、pp147-163.
  
  

2020

• 山末英典：「成人の自閉スペクトラム症」今日の治療指針2021年版、医学書院、2020、pp - .
• 山末英典：「付録：精神科臨床実習の手引き」標準精神医学［第8版］、医学書院、2020、pp - .
  
  

2019

• 山末英典：「日常診療における青年期〜成人期の高機能自閉スペクトラム症の非薬物介入」「日常診療における成人発達障害の支援：10分間で何ができるか」、星和書店、2019、pp 209-219.
• 井上猛、桑原斉、酒井隆、鈴木映二、水上勝義、宮田久嗣、諸川由美代、吉尾隆、渡邉博幸（編）: こころの治療薬ハンドブック（第12版）、星和書店、2019.

2018

• 下山晴彦（監修）、桑原斉、田中康雄、稲田尚子、黒田美保（編著）：公認心理師のための「発達障害」講義、北大路書房、2018.